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Abstract
Background: In 2009, there was an influenza pandemic in South Korea. The aim of this study was to evaluate the
epidemiological, clinical and laboratory characteristics of this infection in children and adults.
Methods: We evaluated the epidemiologic characteristics of patients infected with the 2009 H1N1 influenza A
virus (4,463 patients, age range from 2 mo to 86 y), and the clinical and laboratory findings of 373 inpatients (80/
217 children, ≤ 15 y, had pneumonia and 36/156 adults, > 16 y, had pneumonia) in a single hospital during the
epidemic.
Results: The majority of infected patients (94%) were less than 40 y, and greater than 90% of cases occurred
during a two-month period. The rates of admission and pneumonia were 8.4% (373/4,463) and 2.5% (116/4,463),
respectively. The rates of admission and pneumonia, total duration of fever, the frequency of underlying diseases,
and the values of C-reactive protein and erythrocyte sedimentation rate tended to increase as age increased;
highest rates were found in the ≥ 65 y group. Pneumonia was founded more boys than girls in children, but more
female than male in adults. The adult patients with pneumonia had higher leukocyte counts with lower
lymphocyte differentials than the group without pneumonia, as shown in children group.
Conclusion: Our results suggest that the immunologic reaction to viral insults may be associated with age, sex
and underlying diseases, and that unknown herd immunity may affect populations. The patients with underlying
diseases, especially in older patients may have immunologic insufficiency that is associated with immunologic
consumption by the underlying diseases.
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Background
Since the 2009 H1N1 influenza A virus was first isolated
in North America in spring 2009, there was an influenza
pandemic in South Korea in 2009 as well as in other
countries. Although the mortality of the 2009 H1N1
influenza A virus pandemic (2009 H1N1 flu) has been
reported to be not exceed that of seasonal (inter-pan-
demic) influenza, some epidemiological characteristics of
the pandemic, including its age distribution, differ from
those of seasonal influenza [1,2]. In seasonal influenza,
young infants and older persons are vulnerable and the
m o r t a l i t yr a t ei sh i g h e ri nt h ee x t r e m eo fa g eg r o u p s .
However, in pandemic influenza occurring a 10-40 year
cycle, people of all ages without immunity may be
affected, and young healthy adults can be fatal due to
pandemic influenza [1-4]. During the 20th century, 3
pandemics were documented: 1918 Spanish flu, 1957
Asian flu and 1968 Hong Kong flu. The 2009 H1N1 flu
was the first pandemic in the 21st century [5]. In the
2009 H1N1 flu and in other pandemics, a majority of
infected patients recovered from this infection without
complications. However, some previously healthy
patients developed pneumonia. Patients that developed
severe pneumonia can experience acute respiratory
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death. Nevertheless, the mortality rate of the 2009 H1N1
flu was far less than that of previous pandemics [6-9].
Despite of many clinical and experimental studies, the
pathogenesis of acute lung injury (pneumonia) in influ-
enza infections remains unknown. Some experimental
and clinical studies have suggested that the pathogenesis
of acute lung injury in influenza infections is associated
with excessive host response such as the cell-mediated
immune reaction [10-12]. The immune system of the
host matures through childhood and then declines as
people age [13-15]. Thus, it could be postulated that the
infants and the elderly have either an immature or
reduced immune response to viral infection, respectively.
Furthermore, this may explain the higher mortality rate
in these age groups during the winter influenza season.
However, we previously observed that pneumonia and
s e v e r ep n e u m o n i aw e r em o r ep r e v a l e n ti nt h e5 - 9y
group than in the 0-4 y group [16].
Although the 2009 H1N1flu occurred nearly four dec-
ades after the 1968 Hong Kong flu, thanks to new diag-
nostic tools such as real-time reverse transcriptase-
polymerase chain reaction (RT-PCR) and nationwide
surveillance system, many investigators could more
exactly evaluate the epidemiological and clinical charac-
teristics regarding the 2009 H1N1 flu. In this study, we
aimed to evaluate the epidemiological, clinical and
laboratory features of patients infected with the 2009
H1N1 virus at a single hospital and to compare these
parameters between age groups. Also, we tried to
explain the reasons of the epidemiological characteristics
of the 2009 H1N1 flu, including the lower mortality rate
in healthy persons than in previous pandemics.
Methods
Daejeon is one of the largest cities located central in
South Korea, and its population is 1.48 millions. The
Catholic University of Korea Daejeon St Mary’s Hospital
is one of 5 general hospitals (> 600 beds) in the city and
has 670 beds for children and adults. During the epi-
demic in Korea as the same period of this study (Sep-
tember 1st, 2009 to January 31st, 2010), 5 general
hospitals, including our institution in Daejeon, per-
formed the primary care for the outpatient and inpatient
cases according to the Korea government policy, as the
strategic positional hospitals for 2009 H1N1 flu. There-
fore, the policies of patient care, including use of diag-
nostic tool (RT-PCR) and antivirals (oseltmivir), were
similar among general hospitals in large cities in Korea.
The subjects of this study were all patients who were
positive diagnostic RT-PCR (AccuPower™ in Korea,
BiONEER, Alameda, CA, USA) on nasopharyngeal and
throat swabs, and visited our institution during epidemic
period in Korea.
For the evaluation of epidemiological characteristics of
2009 H1N1 flu, a total of 4,463 patients were analysed.
In addition, we reviewed the medical records and chest
radiographic findings of 373 inpatients (217 children, ≤
15 y and 156 adults, > 16 y) for the evaluation of clinical
characteristics. To compare the clinical and laboratory
findings according to age, we divided the subjects into 4
age groups: the 0-15 y group, the 16-40 y group, the 41-
64 y group and the ≥ 65 y group. The patients that were
less than or equal to 15 y were treated in the Depart-
ment of Paediatrics, and the patients that were greater
than 16 y were treated in the Department of Internal
Medicine. Some data compiled in this study regarding
the ≤ 15 group was previously published [16]. The first
day of fever and/or severe respiratory symptoms such as
dyspnea were regarded as the first day of illness. Fever
was defined as greater than 38°C using an eardrum ther-
mometer. Pneumonia was defined as any infiltration on
chest radiographic findings with clinical symptoms such
as fever and cough. The study was approved by the
Institutional Review Board of the Catholic University of
Korea, Daejeon St Mary’s Hospital.
Statistical analysis
The clinical and laboratory information of the admitted
patients presented as the median and range (minimum
to maximum). Statistical significance was assessed using
the Student’s t-test and the ANOVA test for continuous
variables and the c
2 test and the Linear by linear asso-
ciation method for categorical variables. The data were
analysed using SPSS version 12.0 for Windows (SPSS
Inc., Chicago, IL, USA), and a P value less than 0.05 was
considered significant.
Results
During the study period, a total of 9,269 patients with
influenza-like illness were examined by RT-PCR, and
4,463 patients were positive. Among them, 373 patients,
217 children (≤ 15 y, 80 had pneumonia) and 156 adults
(> 16 y, 36 had pneumonia, 100 patients in the 15-40 y,
35 patients in the 41-64 y and 21 patients in the > 65 y
group), were hospitalized (Table 1).
Epidemiological features of the patients with the 2009
H1N1 virus infection
The median age of the patients (4,463 cases) was 11 y
(range of 2 mo-86 y, mean 15 ± 13.5 y) and the male-
to-female ratio was 1:1 (2,274/2,189). However, there
were more boys in children group and more females in
adult groups (Table 1). The age distribution of the
patients is shown in Figure 1. In total, 48.4% of the
patients were in the 0-10 y group (2,160), 29.8% were in
the 11-20 y group (1,329), 10% were in the 21-30 y
group (447), and 5.8% were in the 31-40 y group (258).
Rhim et al. International Archives of Medicine 2012, 5:13
http://www.intarchmed.com/content/5/1/13
Page 2 of 8Therefore, children and young adults comprised the
majority of the patients (94%). There was a decreasing
trend in the number of patients older than 41 y as
increased age, and the ≥ 65 y group comprised only
0.9% (42) of the total patients (Figure 1 and Table 1).
Over three quarters of the cases occurred during a sin-
gle month (October 18th-November 14th) (Figure 2).
This pattern was similar in both the children and adults
(Figure 2, black and gray bars).
Clinical features of the inpatients with the 2009 H1N1
virus infection
The median age of the 373 hospitalized patients was 10
y (range 2 mo- 86 y, mean 19.4 ± 20.1 y), and the male-
to-female ratio was 1.1:1 (196/177). The total admission
rate due to influenza infection was 8.4% (373/4,463).
The age distribution of the patients admitted to hospital
are shown on Figure 1 (black bar), and these demon-
strated similar patterns to those of the total patient
cohort except older age group. The admission rate of
the 0-10 y was 8.8% (191/2,160), the 11-20 y was 4.7%
(62/1,329), the 21-30 y was 9.2% (41/447), the 31-40 y
was 8.9% (23/258), the 41-50 y was 12.1% (15/124), the
51-60 y was 16.7% (14/84), and the ≥ 61 y was 44.3%
(27/61).
All inpatients received the recommended doses of
oseltamivir and the majority of inpatients received a
broad-spectrum antibiotic. In total, 338 patients (90.6%)
received oseltamivir within 48 h of fever onset. Six adult
patients (4 in the 41-65 y group and 2 in the ≥ 65 y
group) with underlying diseases were infected during
their hospital stay and thesep a t i e n t sw e r ee x c l u d e d
from the subjects. Additionally, four of the infected
patients were pregnant women, and their clinical course
was uneventful. We analysed the chest radiographs of
the inpatients and found that 116 patients had pneumo-
nia (80 children and 36 adults). Pneumonia was detected
in 31.3% (116/373) of the admitted patients, and 2.6%
(116/4,463) of the total infected patients, respectively
(Table 1). No children were treated in the intensive care
unit. However, six adult patients were treated in the
intensive care unit, two had ARDS and 4 were at risk of
deterioration because of underlying diseases. None of
the infections in this study was fatal.
Clinical and laboratory features according to age
We classified the admitted patients into 4 age groups, as
mentioned previously. Interestingly, there were signifi-
cant differences in the male-to-female ratios in the
admitted patients and the pneumonia patients between
children (≤ 15 y) and adults (16-86 y). In the admitted
Table 1 The admission rates and pneumonia cases according to age in the total cohort (n = 4,463)
Age groups 0-15 y
(n = 2971)
16-40 y
(n = 1222)
41-64y
(n = 228)
≥ 65 y
(n = 42)
P
% of total cases 66. 6 27.4 5.1 0.9 -
Male:female ratio 1.1:1 1:1.1 1:1.5 1:2 < 0.001
Admission rate (%, n) 7.3 (217) 8.2 (100) 15.4 (35) 50 (21) < 0.001
Pneumonia (%, n) 2.7 (80) 1.3 (16) 3.9 (9) 26.2 (11) 0.003
Figure 1 Age distribution of the H1N1 virus infected patients
in this study.
Figure 2 Weekly frequency of H1N1 virus infection during
study period.
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children, whereas the ratio was 1:1.4 (64:92) in adults.
Additionally, in the patients with pneumonia the male-
to-female ratio was 3:1(60:20) for the children and 1:2
(12:24) in the adults. There was a correlation between
increased age and an increase in the admission rate and
the frequency of underlying diseases (linear by linear
association test), and the total duration of fever and the
hospitalization (ANOVA test). In laboratory findings,
the C-reactive protein (CRP) and erythrocyte sedimenta-
tion rate (ESR) values displayed similar correlation
(ANOVA test) (Table 2). The ≥ 65 y group showed sig-
nificant differences compared to other age groups in
nearly all of the examined parameters (c
2 test and Stu-
dent’s t-test, data not shown). The frequency of underly-
ing diseases was significantly different among age
groups. Many patients had more than one underlying
diseases and these patients were more prevalent in older
groups. The underlying diseases of the admitted patients
are shown in Table 3.
We previously found that children with pneumonia
had higher leukocytes counts with lower lymphocyte dif-
ferentials than the children without pneumonia [16].
The adult patients with pneumonia had higher leuko-
cytes counts, CRP and ESR values with lower
lymphocyte differentials than the adults without pneu-
monia (Table 4).
Discussion
In this study, we evaluated the epidemiologic character-
istic of the H1N1 virus infected patients of all ages in a
single hospital throughout the epidemic. The age distri-
bution pattern as shown in Figure 1 for our study has
been observed in other regions of Korea [9]. Addition-
ally, other countries found that children and young
adults (< 40 y) comprised a predominant portion of the
infected patient and that older adult groups (> 40-50 y)
were possibly protected from this new viral infection
[9,17-21]. Moreover, the mortality in this pandemic was
not higher than for seasonal influenza and was highest
in the older adult group, which is similar to seasonal
influenza, although the numbers of infected patients in
the older adult group was very small [7-9].
It is unknown what characteristics of the 2009 H1N1
flu caused the trends identified in this study. In Korea,
because the rates of seasonal influenza vaccination dur-
ing the recent decade was relatively even in the adult
population with higher rates of vaccination in the under
5 y group and the older than 60 y group, it is unlikely
that the vaccination status of the population was
Table 2 Clinical and laboratory findings of the admitted patients according to age (n = 373)
Age groups 0-15 y
(n = 217)
16-40 y
(n = 100)
41-64y
(n = 35)
≥ 65 y
(n = 21)
P
Clinical Characteristics
Age, mean (y) 6.2 ± 3.7 25.2 ± 7 51.9 ± 6.7 74 ± 5 < 0.001
Male/female 132/85 45/55 14/21 5/16 < 0.001
Duration of fever (d)
Before admission 2.0 ± 1.9 2.0 ± 1.1 1.7 ± 1.5 1.5 ± 1.3 0.045
Total duration 2.3 ± 1.0 2.9 ± 1.3 3.0 ± 1.7 4.1 ± 3.0 < 0.01
Oseltamivir, < 48 h* 205 (94) 89 (89) 29 (83) 15 (71) NS
Hospitalisation (d) 4.9 ± 1.5 5.4 ± 2.2 5.2 ± 2.9 8.8 ± 5.1 < 0.001
Pneumonia
Number (%) 80 (37) 16 (16) 9 (29) 11 (52) NS
Male/female 60/20 4/11 4/5 3/8 < 0.001
Underlying diseases 17 (7.8) 15 (15) 15 (42.9) 16 (76.2) < 0.001
Laboratory findings
Haemoglobin (g/dL) 12.6 ± 0.9 13.5 ± 2.1 13.1 ± 1.6 12.9 ± 1.4 < 0.001
Leukocyte (×10
9/L) 7.4 ± 3.6 6.4 ± 2.6 6.8 ± 2.8 7.6 ± 3.2 < 0.001
Neutrophil (%) 63 ± 19 66 ± 15 71 ± 14 64 ± 17 NS
Lymphocyte (%) 27 ± 17 23 ± 13 20 ± 12 24 ± 14 0.037
Monocyte (%) 9 ± 4 8 ± 4 8 ± 4 9 ± 4 NS
Platelet (×10
9/L) 230 ± 59 202 ± 46 204 ± 51 198 ± 55 0.001
CRP (mg/dL) 1.6 ± 2.0 2.4 ± 3.8 3.8 ± 4.6 6.1 ± 6.9 < 0.001
ESR (mm/h) 17 ± 12 19 ± 17 37 ± 22 42 ± 19 < 0.001
CRP; C-reactive protein, ESR; erythrocyte sedimentation rate. NS, statistically non-specific
* Number (%) of patients who received oseltamivir treatment within 48 h of fever onset
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addition, the results from serologic studies on the cross-
reactive antibody response to the 2009 H1N1 virus
b e f o r et h ep a n d e m i ci na l la g eg r o u p sw e r ed i f f e r e n t
among the populations [22-25]. In Korea, prior to the
pandemic the seroprevalence of antibodies that were
cross-reactive to the H1N1 virus were 20.0% in the 19-
59 y group and 27.3% in the older than 60 y group with
no statistical differences among adult groups [23].
Dudareva et al. in Germany reported that those younger
than 50 y group had highest levels of cross-reactive anti-
bodies prior to the pandemic and the highest infection
rates. Furthermore, they proposed that one of the possi-
ble reasons for the lower risk of infection among older
persons could be pre-existing immunity not detectable
by cross-reactive antibodies [24].
Given that this pandemic reemerged nearly 4 decades
after last pandemic (1968 Hong Kong flu), it is possible
that cross-immunity and/or an unknown herd immunity
against a previous pandemic influenza virus (known as
H3N2) may have played a role on populations in this
pandemic, although the virus subtypes were different.
Previous epidemiological studies on measles in the
South Pacific islands, including Hawaii, have provided
the new insights into new pathogens and herd immunity
[26-28]. Epidemiologically, it is well documented that
when a new pathogenic virus, such as the measles virus,
is introduced into an immune-naive isolated population,
nearly all inhabitants of all ages are affected, and that
the severity of the disease and the mortality rate is very
high (> 10-50%). In addition, the mortality is paradoxi-
cally the highest in the healthiest age-group (20-40 y)
with the most active immune function. Then, in subse-
quent epidemics the severity of the disease begins to
weaken because of unknown herd immunity [26,27]. In
Faröe Islands, when the measles were re-introduced 65
years after the first disaster, the older than 65 popula-
tion was protected from measles, and the mortality in
this population was far less than the first attack [26,28].
Therefore, it is possible that the epidemiological charac-
teristics of pandemic influenza are similar to those of
measles. The severity of influenza in this pandemic was
far less than that of the Spanish flu, which was a devas-
tating disaster, because of the highest mortality rate in
young adult groups. In addition, changing epidemiology
has been observed for some viral infections, such as
hemorrhagic fever with renal syndrome after the intro-
duction of the vaccine in Korea [29], and acquired
immunodeficiency syndrome (AIDS) after the introduc-
tion of antivirals [30]. An initially severe disease with
high mortality can transform into a milder phenotype
over time.
The characteristic explosive infection rate during the
pandemic, which is shown in Figure 2, has also been
reported in other regions of Korea and other countries
[7-9,17-21]. This epidemiological pattern was observed
in countries where vaccination for H1N1 virus was not
performed, including Australia and New Zealand
[17,18,21], and in countries where the vaccination
Table 3 Underlying diseases of the admitted patients
according to age
Age groups 0-15 y
(n = 217)
16-40 y
(n = 100)
41-64 y
(n = 35)
≥ 65 y
(n = 21)
Total cases (n,%) 17 (7.8) 15 (15) 15 (42.9) 16 (76.2)
Hypertension 1 2 6
Chronic lung disease
COPD 3 7
Asthma 10 4 2 3
Others 1 2
Cancer 1 1
Diabetes 3 2 3
Neurologic disorder 4 1 1 3
Heart disease 1 1 5
Chronic liver disease 1 2 4 3
Chronic renal disease 1 3 2 1
Autoimmune disorder 2 1
Immunosuppresion 1 3 1 1
Pregnancy* 4
COPD; chronic obstructive pulmonary disease
* Pregnancy was not defined as underlying disease
Table 4 Clinical and laboratory findings of adults
patients (> 16 y) with and without pneumonia (n = 156)
Group No Pneumonia
(n = 120)
Pneumonia
(n = 36)
P
Clinical characteristics
Mean age (y) 35 ± 17 48 ± 22 0.002
Male/Female 53/67 11/25 NS
Duration of fever (d)
Before admission 1.8 ± 1.2 2.1 ± 1.5 NS
Total 3.2 ± 2.9 3.9 ± 2.3 NS
Hospitalization (d) 5.2 ± 2.9 7.9 ± 3.8 < 0.001
Oseltamivir, < 48 h* 103 (86.7) 29 (80.6) NS
Laboratory findings
Haemoglobin (g/dL) 13.4 ± 2.0 12.5 ± 2.1 0.02
Leukocyte (×10
9//L) 6.2 ± 2.4 7.9 ± 3.5 0.009
Neutrophil (%) 64 ± 15 76 ± 12 < 0.001
Lymphocyte (%) 24 ± 14 16 ± 9 < 0.001
Monocyte (%) 10 ± 4 7 ± 4 0.001
Platelet (×10
9/L) 205 ± 50 201 ± 69 NS
CRP (mg/dL) 2.3 ± 4.0 6.6 ± 6.5 0.001
ESR (mm/h) 22 ± 19 35 ± 22 0.001
a Number (%) of patients who received oseltamivir treatment within 48 h of
fever onset
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The rapid decline in the number of infection might also
be explained by unknown herd immunity to pandemic
influenza virus [16].
Although it was reported that a significant proportion
of the populations can be infected with pandemic influ-
enza, up to 40-50%, based on previous seroprevalence
studies, there have been few population based data for
infection rates during previous pandemics because of
the lack of diagnostic tools such as RT-PCR [1,2,4]. In
Korea during the 2009 H1N1 flu period, Korea Centers
for Disease Control and Prevention reported that a total
of 740,835 patients (1.5% of the 49 millions of total
population in South Korea, 1,492 per100,000 persons)
had been infected with H1N1 virus and confirmed by
RT-PCR, and also reported that 225 of these patients
died [9]. Therefore, there may have been many patients
with asymptomatic or mild phenotypes in the 2009
H1N1 flu, regardless of the half RT-PCR positivity
caused by febrile influenza-like illness. Follow-up sero-
prevalence studies conducted after the 2009 H1N1 flu
have shown that greater than 40-50% of the examined
samples from young adults were positive [24,25], and
these findings support the possibility of the unknown
herd immunity to pandemic influenza. In present cohort
study, the calculated incidence of pneumonia in the
2009 pandemic was 2.6% of the infected patients with
no fatal cases. The mortality rate in Korea was reported
as 0.3 per 1,000 patients (0.03%), and other countries
reported a range of mortality rates from 0.01 to 0.05%
[7,8,17,19,21].
The male-to-female ratio was 1:1 for the total patients
(4,463). However, in the inpatient group there was a
higher number of boys than girls in the children (1.6:1)
and a higher number of female than male in the adults
(1:1.4). The male-to-femaler a t i o sa m o n gt h o s ew i t h
pneumonia showed a similar trend: 3:1 in the children
and 1:2 in the adults. This tendency has been previously
reported by studies on children and/or adult group
[3,18,31,32]. These findings suggest that the immunolo-
gic reaction to H1N1 virus infection is associated with
age and sex.
In this study, we found that clinical parameters such
as admission rate, the frequency of underlying diseases,
the rate of pneumonia and the values of laboratory para-
meter, such as CRP and ESR were associated with the
increasing age. Especially, in the ≥ 65 y group (mean
age 74 y), which showed significant difference compared
to the other age groups all parameters. The ≥ 65 y
g r o u pm a d eo n l y0 . 9 %o ft h et o t a lH 1 N 1v i r u si n f e c t e d
patients (42/4,463). However, 5.6% of the admitted
patients (21/373) and 9.5% of the pneumonia patients
(11/116) were ≥ 65 y. It has been well documented that
influenza can exacerbate underlying chronic disease,
including asthma, chronic obstructive pulmonary disease
(COPD), chronic hepatic or renal insufficiency, diabetes,
or other cardiovascular conditions [6-9]. Given that a
majority of H1N1 infected patients recovered without
developing pneumonia, it is possible that the previously
healthy patients that did develop progressive pneumonia
may have had a hyperactive immunologic reaction to
the viral insults [10-12]. However, because the ultimate
recovery from viral infection should be controlled by
immune system of the host, including T cells, we
hypothesised that the patients with underlying diseases
that require immune cells to control the diseases, may
have an immunological defect as a result of immunolo-
gical consumption. Patients with underlying diseases,
especially older patients who have natural immune
weakness, may experience a delayed recovery from viral
insult or die from the deterioration of underlying dis-
eases. Thus, it is possible that in these patient groups,
the cause of mortality may be an individual immunolo-
gical defect rather than viral infection. This phenom-
enon has been observed in other systemic infection
including severe acute respiratory syndrome (SARS) by
corona viruses and was recently observed in hemolytic
uremic syndrome, which is caused by toxin-producing
E. coli [33,34]. Furthermore, the proportion of these
older patients (> 60 y) with underlying diseases
accounted for > 50% of the fatal cases in Korea, despite
the small number of total infections in this group (1.2%
of the total infected patients) and in this study [9,35].
We previously reported that the children with pneu-
monia had higher leukocytes counts with lower lympho-
cyte differentials than the group without pneumonia,
and that these parameters were associated with the
severity of pneumonia [16]. In this study, we also found
that the adult pneumonia patients had higher leukocytes
counts with lower lymphocyte differentials, and higher
CRP and ESR values compared to the group without
pneumonia.
Because there have been no controlled-clinical trials
that use corticosteroids to treat influenza patients since
the last pandemic (1968 Hong Kong flu), the efficacy of
corticosteroids on influenza infection is not known [36].
We previously reported that treating children with
severe pneumonia with early corticosteroids effectively
prevented disease progression [10,16,37]. In the present
adult series, two previously healthy female patients (30 y
and 42 y) had progress pneumonia and developed
ARDS. Early infusion of corticosteroid (methylpredniso-
lone) resulted in rapid recovery without mechanical ven-
tilation therapy. The results of corticosteroid treatment
on severely affected adult ARDS patients are also con-
troversial [38,39]. It is possible that the numbers of
patients with underlying diseases and different modal-
ities for respiratory care among the study groups may
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tality after treatment with immune modulators (corti-
costeroids) for patients with severe ARDS patients
[38,39]. In addition, in this pandemic a part of pneumo-
nia patients who were previously healthy presented with
acute severe respiratory distress that was similar to an
acute asthmatic attack [10]. Many of these patients may
have been treated with early corticosteroids because it
was assumed that they were having an asthmatic epi-
sode. Therefore, if these patients improved after corti-
costeroid treatment, they would not be included in the
corticosteroid treated ARDS groups. The effect of corti-
costeroids on viral replication is controversial [40,41].
Additionally, it is unknown whether the virus particle
itself or other mediators induce inflammation in lung
lesions [10]. The corticosteroids may reduce the sys-
temic immune reaction caused by hyperactive immune
cells (T cells) with hypercytokinemia [10,38].
The initial lung injury that is caused by primary viral
infection leads to secondary bacterial infection and
further aggravation of ARDS [4]. Previous studies
reported that 10-20% of the patients with severe pneu-
monia were co-infected with bacteria and that greater
than 50% of the fatalities in pandemics were caused by
co-infection with bacteria including S. pneumoniae, S.
aureus and S. pyrogens [4,42]. These findings suggest
that for previously healthy patients, early control of the
initial acute lung injury may be essential to prevent
ARDS and further lung injuries [10].
There are some limitations to this study. This retro-
spective observational study has a limited number of
adult patients. Although our epidemiological data
appeared to be similar to the nationwide data from the
Korea government [9], the clinical data may not be a
representative on 2009 H1N1 flu in Korea. There might
be some differences on the policies of patient care,
including admission and discharge, among clinicians in
both departments. As for pneumonia patients, we did
not perform extensive microbiological testing for other
pathogens, we cannot rule out the possibility of co-
infection with other respiratory pathogens.
Conclusions
In 2009 H1N1 pandemic in Daejeon, Korea, the majority
of infected patients (94%) were under 40 y, and males
and females were equally affected. Pneumonia was
o b s e r v e di n2 . 6 %o fi n f e c t e dp atents (116/4,463), and
pneumonia was more predominant in male than female
children, but more predominant in adult females than in
adult males. The epidemiologic characteristics of this
pandemic suggest that unknown herd immunity may
have acted on the populations. The greater than 65 y
group had the highest rate of underlying diseases and
higher admission rate, pneumonia rate, total duration of
fever, and CRP and ESR values than other age groups.
These results indicated that these patients may have an
immunologic defect that is associated with immunologic
consumption by underlying diseases. Our results suggest
that immunologic reaction of the host to viral insults is
associated with age, sex and underlying diseases.
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